Novo Nordisk in global pole position
Over the last three years the Danish diabetes giant, Novo Nordisk, has proved the fastest growing and highest earning pharmaceutical company in the world.
by Stefan Singh Kailay
Novo Nordisk belongs to the elite of the global pharmaceutical industry. Although the Danish company is ‘only’ the world’s fifth largest in terms of turnover, it is top of the heap when it comes to growth.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
